Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes

Journal of General Internal Medicine

Volumn 28, Issue 2, 2013, Pages 208-215

  Egede, Leonard E ^a,b   Lynch, Cheryl P ^a,b   Gebregziabher, Mulugeta ^a,b   Hunt, Kelly J ^a,b   Echols, Carrae ^a   Gilbert, Gregory E ^a   Mauldin, Patrick D ^b,c,d  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Division of General Internal Medicine   (United States)

Author keywords

diabetes; medication non adherence; mortality; race ethnicity; veterans

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; CEREBROVASCULAR DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DEPRESSION; ETHNICITY; FEMALE; HAZARD RATIO; HISPANIC; HUMAN; HYPERTENSION; INSULIN TREATMENT; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COMPLIANCE; PSYCHOSIS; RACE; VETERAN;

ADMINISTRATION, ORAL; AFRICAN AMERICANS; AGED; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MEDICAL RECORD LINKAGE; MEDICATION ADHERENCE; MIDDLE AGED; RISK FACTORS; UNITED STATES; VETERANS;

EID: 84873443183     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-012-2200-8     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008.
2. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available online: http://www.cdc.gov/nchs/ data/nvsr/nvsr58/nvsr58-19.pdf. Accessed August 3, 2012.
3. Mokdad, A. Diabetes trends in the U.S.: 1990-1998. Diabetes Care. 2000;23(9): 1278-83. [PMID: 10977060].
4. Cowie C. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29(6):1263-8.
5. Adams AS, Trinacty CM, Zhang F, et al. Medication adherence and racial differences in A1C control. Diabetes Care. 2008;31(5):916-21.
6. Grant R, Adams AS, Trinacty CM, et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30(4):807-12.
7. Trinacty CM, Adams AS, Soumerai SB, et al. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res. 2009;9:24.
8. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27(9):2149-53.
9. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-41.
10. Heisler M, Choi H, Rosen AB, et al. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care. 2010;48(2):87-94.
11. Kuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetes medications, diabetes complications, and mortality in older Mexican Americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care. 2003;26(11):3054-60.
12. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11):2958-71.
13. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(Suppl 2):B10-21.
14. West AN, Lee RE, Shambaugh-Miller MD, et al. Defining "rural" for veterans' health care planning. J Rural Health. Fall;26(4):301-9. [PMID: 21029164].
15. Department of Veterans Affairs Field Research Advisory Committee. (2004). Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Field Research Advisory Committee Operating Procedures. Available online: http://www.research.va.gov/about/frac/FRAC-ops.pdf Accessed August 3, 2012.
16. SAS statistical software, version 9.2. SAS Institute Inc, Cary, NC.
17. Cramer JA, Benedict A, Muszbek N, et al. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62:76-87.
18. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005;27(7):1064-73.
19. Lynch CP, Gebregziabher M, Echols C, Gilbert GE, Zhao Y, Egede LE. Racial Disparities in All-Cause Mortality Among Veterans with Type 2 Diabetes. J Gen Intern Med. Jun 8 2010. [PMID: 20532659].
20. Jha AK, Shlipak MG, et al. (2001). "Racial differences in mortality among men hospitalized in the Veterans Affairs health care system." JAMA. Jan 17 2001;285(3): 297-303. [PMID: 11176839].
21. Volpp KG, Stone R, Lave JR, et al. Is thirty-day hospital mortality really lower for black veterans compared with white veterans? Health Serv Res. 2007;42(4):1613-31.
22. Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care. 2005;28:78-83.